Summary
Unable to evaluate the provided AI claims against the supplied prescribing information because the supplied prompt contains only label excerpts for a specific product (Aspirin and Extended-Release Dipyridamole Capsules) and does not include the AI-generated claims in a directly evaluable format. Additionally, most AI claims concern aspirin monotherapy dosing/evidence (e.g., pain dosing, rheumatoid arthritis, ACC dosing guidance) and these are not present in the provided label text.
Category Scores
Accurate Statements
Aspirin should not be given to children or teenagers with viral infections because of the risk of Reye syndrome.
Contraindications 4.3 Reye Syndrome: 'Do not use aspirin in children or teenagers with viral infections because of the risk of Reye syndrome.'
Unsupported Statements
For pain relief, adults can take 325–650 mg of aspirin every 4–6 hours as needed.
No adult analgesic dosing instructions (dose range and frequency) are provided in the supplied label excerpts.
Taking more than 1,000 mg of aspirin per day can increase the risk of stomach ulcers and bleeding.
The provided label excerpts discuss bleeding and GI side effects generally, but do not provide a threshold daily aspirin dose (e.g., >1,000 mg/day) tied to ulcer/bleeding risk.
For anti-inflammatory effects, 1,000–2,000 mg of aspirin per day was reported as effective in reducing inflammation in patients with rheumatoid arthritis.
No rheumatoid arthritis indication or anti-inflammatory efficacy dosing (1,000–2,000 mg/day) is present in the supplied label excerpts.
A daily dose of 81–325 mg of aspirin is recommended by the American College of Cardiology for patients at high risk of cardiovascular events.
The supplied label excerpts do not mention ACC or any specific cardiology guideline dose recommendations.
Pregnant or breastfeeding women should take aspirin only under the guidance of a healthcare professional because it may increase the risk of bleeding and other complications.
The label excerpts include pregnancy/lactation risk information (bleeding risk during labor; milk salicylic acid low levels) but do not state an instruction that pregnant/breastfeeding women 'should take aspirin only under the guidance' framing as written.
Aspirin should be avoided in individuals with bleeding disorders, such as hemophilia, because it can increase the risk of bleeding.
The supplied label excerpts state aspirin/ER dipyridamole increases bleeding risk and list risk factors and ulcer disease precautions, but do not specifically mention bleeding disorders/hemophilia as contraindications or guidance.
Taking too much aspirin can lead to serious side effects, including stomach ulcers, bleeding, and kidney damage.
The overdosage section focuses on dipyridamole-dominant overdose signs, salicylate toxicity, and general management; kidney damage and specific linkage of 'stomach ulcers, bleeding, and kidney damage' to overdose are not stated in the provided excerpts.
Contradictions
Low
AI Statement
Not provided in the prompt.
Label Reference
No label basis available because this is not an evaluable medical claim.
Important Omissions
The AI claims and evaluation were not provided in a way that clearly specifies the exact product/label section coverage needed to verify all claims (e.g., whether the claims refer to 'Aspirin and Extended-Release Dipyridamole Capsules' vs aspirin monotherapy).
Importance:
Moderate
Boxed warning assessment: none of the supplied label excerpts include a boxed warning section, so alignment regarding any boxed warnings cannot be assessed.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
High
Several claims provide specific aspirin dosing/effectiveness and specific patient-group recommendations that are not supported by the provided prescribing information excerpts. Using unsupported dosing/indications or patient selection criteria could lead to inappropriate use relative to the supplied label.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
Yes |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Most AI claims (pain dosing, anti-inflammatory RA dosing, ACC guideline dosing, bleeding disorders/hemophilia, and overdose consequences including kidney damage) are not supported by the supplied FDA label excerpts.
Suggested Improvement
Limit claims to information explicitly present in the provided label excerpts (e.g., Reye syndrome pediatric viral infections; bleeding risk and GI side effects; avoid in severe renal failure; pregnancy/lactation milk/bleeding considerations; overdose management concepts). Do not state specific aspirin dosing ranges or guideline recommendations unless they appear in the label text provided.